RedHill Biopharma Ltd.
Sphingosine kinase 2 inhibitor for treating coronavirus infection
Last updated:
Abstract:
The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.
Status:
Grant
Type:
Utility
Filling date:
15 Oct 2021
Issue date:
21 Jun 2022